BioForm Medical, Inc. (BFRM) reported first quarter net loss of $559 thousand, or $0.01 per share, compared to net loss of $7.8 million or $0.17 per share last year.
Net sales grew to $18.27 million from $15.67 million in the same quarter last year.
On average, 3 analysts polled by Thomson Reuters expected the company to report loss of $0.07 per share, on revenues of $15.59 million. Analysts' estimates typically exclude special items.
BioForm Medical is updating its financial guidance for the full fiscal year 2010. Revenues are now expected to be approximately $70-74 million, compared to $64-70 million provided earlier. Net loss is now expected to be less than $6 million.
Analysts expect loss of $0.21 per share, on revenues of $67.06 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.